Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 1
2021 2
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Radiomics in cone-beam breast CT for the prediction of axillary lymph node metastasis in breast cancer: a multi-center multi-device study.
Zhu Y, Ma Y, Zhai Z, Liu A, Wang Y, Zhang Y, Li H, Zhao M, Han P, Yin L, He N, Wu Y, Sechopoulos I, Ye Z, Caballo M. Zhu Y, et al. Eur Radiol. 2024 Apr;34(4):2576-2589. doi: 10.1007/s00330-023-10256-4. Epub 2023 Oct 2. Eur Radiol. 2024. PMID: 37782338
CLINICAL RELEVANCE STATEMENT: The findings support potential clinical use of radiomics for predicting axillary lymph node metastasis in breast cancer patients and addressing the limited axilla coverage of cone-beam breast CT. KEY POINTS: Contrast-enhanced cone-beam breast …
CLINICAL RELEVANCE STATEMENT: The findings support potential clinical use of radiomics for predicting axillary lymph node metastasis in brea …
Comparison of background parenchymal enhancement (BPE) on contrast-enhanced cone-beam breast CT (CE-CBBCT) and breast MRI.
Ma Y, Liu A, Zhang Y, Zhu Y, Wang Y, Zhao M, Liang Z, Qu Z, Yin L, Lu H, Ye Z. Ma Y, et al. Eur Radiol. 2022 Aug;32(8):5773-5782. doi: 10.1007/s00330-022-08699-2. Epub 2022 Mar 23. Eur Radiol. 2022. PMID: 35320411
The 2(nd) week of menstrual cycle timing is suggested as the optimal examination period for CE-CBBCT. KEY POINTS: CE-CBBCT showed substantial agreement and comparable inter-reader reliability with MRI for BPE evaluation. ...
The 2(nd) week of menstrual cycle timing is suggested as the optimal examination period for CE-CBBCT. KEY POINTS: CE-CBBCT showed sub …
Dedicated breast CT: state of the art-Part II. Clinical application and future outlook.
Zhu Y, O'Connell AM, Ma Y, Liu A, Li H, Zhang Y, Zhang X, Ye Z. Zhu Y, et al. Eur Radiol. 2022 Apr;32(4):2286-2300. doi: 10.1007/s00330-021-08178-0. Epub 2021 Sep 3. Eur Radiol. 2022. PMID: 34476564 Review.
The potential for future screening with breast CT is also addressed. KEY POINTS: Dedicated breast CT is an emerging modality with enormous potential in the future of breast imaging by addressing numerous clinical needs from diagnosis to treatment. ...New imaging modalities …
The potential for future screening with breast CT is also addressed. KEY POINTS: Dedicated breast CT is an emerging modality with eno …
Dedicated breast CT: state of the art-Part I. Historical evolution and technical aspects.
Zhu Y, O'Connell AM, Ma Y, Liu A, Li H, Zhang Y, Zhang X, Ye Z. Zhu Y, et al. Eur Radiol. 2022 Mar;32(3):1579-1589. doi: 10.1007/s00330-021-08179-z. Epub 2021 Aug 3. Eur Radiol. 2022. PMID: 34342694 Review.
Proposed methods of how to address these technical challenges are also discussed. KEY POINTS: Advantages of breast CT include no tissue overlap, improved patient comfort, rapid acquisition, and concurrent assessment of microcalcifications and contrast enhancement. ...
Proposed methods of how to address these technical challenges are also discussed. KEY POINTS: Advantages of breast CT include no tiss …
Cone-beam breast CT features associated with HER2/neu overexpression in patients with primary breast cancer.
Zhu Y, Zhang Y, Ma Y, Li H, Liu A, Han P, Yin L, Lv N, Li Z, Lu H, Liu P, Ye Z. Zhu Y, et al. Eur Radiol. 2020 May;30(5):2731-2739. doi: 10.1007/s00330-019-06587-w. Epub 2020 Jan 3. Eur Radiol. 2020. PMID: 31900700
CONCLUSIONS: CBBCT features could be used to prognosticate HER2 status independently, which are potentially complementary to histopathologic result and helpful in guiding biopsy. KEY POINTS: Dmax, lobulation, deltaCT, and calcification morphology are independent predictors …
CONCLUSIONS: CBBCT features could be used to prognosticate HER2 status independently, which are potentially complementary to histopathologic …